In this study, we aimed to examine the association between age at menarche and gestational diabetes mellitus (GDM). Data were from 4,749 women participating in the Australian Longitudinal Study on Women's Health between 2000 and 2012. Age at menarche was reported at baseline in 2000 when women were aged 22-27 years. During 12 years of follow-up, information on GDM diagnosis was obtained for each live birth. Log-binomial regression analysis was used to estimate relative risks and 95% confidence intervals. Analyses adjusted for mother's highest completed educational qualification, nulliparity, polycystic ovary syndrome, physical activity, and body mass index. Mean age at menarche was 12.9 years (standard deviation, 1.4). A first diagnosis of GDM was reported by 357 women (7.5%). Compared with women with menarche at age 13 years, women who had their first menstruation at age ≤11 years had a 51% higher risk of developing GDM (95% confidence interval: 1.10, 2.07) after adjustment for GDM risk factors. Our findings indicate that a young age at menarche may identify women at higher risk of GDM. Further prospective studies are needed to confirm our findings and to elucidate the role of early-life exposures in age at menarche and subsequent GDM risk.
The prevalence of type 2 diabetes is increasing globally, with the greatest rise occurring in adults under 50 years of age (1, 2) . It has therefore become increasingly important to identify risk factors that can be used to promote early prevention. Results from a meta-analysis by Janghorbani et al. (3) suggested that younger age at menarche (age at onset of first menstruation in girls) is associated with higher risk of type 2 diabetes. Age at menarche is determined by genetic and environmental factors during the perinatal period and childhood (4) , and these findings support the "developmental origins of health and disease" hypothesis that early-life influences can alter the risk of later disease.
Type 2 diabetes shares many features with gestational diabetes mellitus (GDM). Pregnancy has been indicated as a "stress test" for type 2 diabetes relatively early in life, as more than 50% of women with GDM develop type 2 diabetes within 5-10 years following pregnancy (5) . GDM is an increasingly common complication of pregnancy, and it has long-lasting health consequences for both mothers and their children (5) (6) (7) . Examining the association between age at menarche and risk of developing GDM is of significant clinical and public health importance, given the global trends of declining age at menarche and increasing prevalence of obesity and GDM (2, 8) . Identification of women at risk of GDM at an early life stage may allow early health monitoring and intervention. Current evidence on the association between menarche and GDM is limited to inconsistent findings from 2 previously published US studies (9, 10) . Younger age at menarche was associated with higher risk of GDM among women in Nurses' Health Study II (9) but not in the Omega Cohort Study (10) . The association needs further investigation in different populations.
The aim of this analysis was to examine the relationship between age at menarche and development of GDM in a population-based study of reproductive-aged Australian women.
METHODS

Study design and participants
The Australian Longitudinal Study on Women's Health (ALSWH) is an ongoing population-based cohort study of factors affecting the health and well-being of Australian women. Women were randomly selected from the national Medicare health insurance database, which includes all Australian citizens and permanent residents. Women living in rural and remote areas were intentionally oversampled. Full details on the study design, recruitment methods, and response rates have been published previously (11, 12) .
Our analysis included data from a cohort of women born between 1973 and 1978. The first ALSWH survey, carried out in 1996, was completed by a nationally representative sample of 14,427 women aged 18-23 years (11). Selfadministered questionnaires were sent to participants every 3-4 years. Response rates for surveys 2-6 were 67.2% (n = 9,688), 62.9% (n = 9,081), 63.4% (n = 9,145), 56.8% (n = 8,200), and 55.5% (n = 8,009) of baseline response, respectively. Nonresponse was found to be related to baseline characteristics (less education, financial stress, smoking, being unmarried, and having no children); however, estimates of longitudinal associations were found not to be biased by the loss to follow-up (13) . Age at menarche was reported in survey 2 in 2000 (ages 22-27 years), and this was used as the baseline for the present study. Our study in- , and 2012 (survey 6, ages 34-39 years); had no history of GDM or type 1 or type 2 diabetes; and had no missing data on age at menarche, GDM, or relevant covariates (see Web Figure 1 , available at http://aje.oxfordjournals.org/).
Age at menarche
Age at menarche was assessed in survey 2 when the women were aged 22-27 years, using the question, "What age were you when you had your first menstrual period?" Age at menarche was reported in years and was categorized as ≤11, 12, 13, 14, or ≥15 years.
Gestational diabetes mellitus
GDM was ascertained from self-reported physician diagnosis in each survey and for each live birth, using the question, "Were you diagnosed or treated for gestational diabetes?" Women with GDM before survey 2 (baseline) were excluded. Incidence of GDM was defined as a first case of GDM between survey 2 (2000) and survey 6 (2012) . During the study period, diagnostic criteria for GDM in Australia included a 1-hour venous plasma glucose level greater than or equal to 7.8 mmol/L after a 50-g glucose load or a 1-hour venous plasma glucose level greater than or equal to 8.0 mmol/L after a 75-g glucose load. Diagnosis was confirmed with a 75-g oral glucose tolerance test (fasting) with a venous plasma glucose level of ≥5.5 mmol/L at 0 hours and/or a venous plasma glucose level of ≥8.0 mmol/L at 2 hours (14) . Australia has a standard of universal GDM screening of all women (15) . A reliability study carried out in a subgroup of women from New South Wales (n = 1,914) demonstrated high agreement (91%) between self-reported GDM diagnosis in our study and administrative data records (16) .
Covariates
Self-reported information on birth weight, weight during childhood (age 10 years), mother's highest educational qualification, the participant's own highest educational qualification, nulliparity, and diagnosis of polycystic ovary syndrome was collected at baseline. Physical activity scores were derived from validated questions on frequency and duration of walking (for recreation or transport) and reported information on moderate-and vigorous-intensity physical activity in the last week. Level of physical activity was categorized as sedentary/low (<600 metabolic equivalent of task (MET)-minutes/week), moderate (600-1,199 MET-minutes/week), or high (≥1,200 MET-minutes/week) (17) . Body mass index (BMI) was computed as weight (kg) divided by the square of height (m) and was categorized as underweight (BMI <18.5), healthy weight (BMI 18.5-24.9), overweight (BMI 25.0-29.9), or obese (BMI ≥30.0). Women who were pregnant at the time of the survey were asked to report their prepregnancy weight.
Statistical analysis
Baseline characteristics were determined for women who developed and did not develop GDM during follow-up according to categories of age at menarche. Differences between groups were compared using t tests, analysis of variance, or χ 2 tests. Log-binomial regression analysis was used to estimate relative risks and 95% confidence intervals for the association between age at menarche and incident GDM. Covariates were identified based on a priori knowledge of common causes for age at menarche and GDM (confounders), as well as known adulthood risk factors for GDM that may also be associated with age at menarche (potential mediators). Backward selection was used to identify relevant covariates, with those that did not affect the estimates not being included in the final models. We adjusted for mother's highest educational qualification as a marker of early-life exposures in the first model, before adjusting for the baseline factors nulliparity, polycystic ovary syndrome, physical activity (model 2), and BMI (model 3). Birth weight and weight during childhood (age 10 years) were not included in the models, since these were no longer significant covariates when baseline/adulthood BMI was taken into account. Adjustment for maternal age, country of birth, the woman's own highest completed educational qualification, total energy intake, and previous macrosomia did not change the estimates.
We conducted additional analyses to test the consistency of our findings. First, to evaluate effect modification and identify potential differences in the magnitude of the association between age at menarche and GDM risk in subgroups of women, we included an interaction term in the model and performed analyses stratified by risk factors for GDM, including birth weight, weight during childhood, mother's and participant's own highest completed educational qualification, diagnosis of polycystic ovary syndrome, parity, physical activity, and BMI. Second, in addition to adjusting the association for baseline BMI, we examined the influence of timing of BMI by including prepregnancy BMI at the time of the survey prior to the index pregnancy as a covariate in the analysis. Third, we compared baseline characteristics of women included in and excluded from the analysis due to missing covariate data using t tests or χ 2 tests. A multiple imputation analysis was performed to assess the influence of participant exclusions that resulted from missing covariate data (18) . The following SAS (SAS Institute, Inc., Cary, North Carolina) procedure was performed. First, PROC MI was used to create 20 imputed data sets. Covariates included in the regression analysis, as well as variables on the woman's own highest completed educational qualification, total energy intake, birth weight, childhood weight, BMI at the time of the survey prior to baseline (survey 1; 1996) and the survey after baseline (survey 3; 2003), preferred weight, number of times the woman had been on a diet, and number of times the woman had lost weight on purpose, were included in the imputation model. Second, log-binomial regression analyses were performed on each of the imputed data sets. Third, these results were then analyzed using MIANALYZE to create combined estimates and confidence intervals that appropriately accounted for the variance within and between imputed data sets. Lastly, to examine the potential influence of unequal follow-up due to attrition, we performed survival analysis. Survival time for each woman was defined as the time from baseline to GDM pregnancy or loss to follow-up, whichever came first.
Statistical analyses were conducted using SAS software, version 9.4. P values less than 0.05 were considered statistically significant.
RESULTS
Among 4,749 women aged 25 years (standard deviation (SD), 1.4) at baseline who reported having a live birth during 12 years of follow-up, 357 women (7.5%) reported a first diagnosis of GDM. Women who developed GDM were, at baseline, more likely to not know their mother's highest educational qualification, to be nulliparous (no previous births), to be sedentary or have a low physical activity level, to be overweight or obese, and to have a diagnosis of polycystic ovary syndrome (Table 1) .
Women had a mean age at menarche of 12.9 years (SD, 1.4). Those with early menarche (≤11 years) were more likely to report being overweight in childhood and to have a mother with a low level of education or an unknown highest educational qualification (Table 2 ). These women were also more likely to have a sedentary/low physical activity level and to be overweight or obese at baseline.
Women with early menarche (≤11 years) had a significantly higher risk of developing GDM (relative risk (RR) = 1.68, 95% confidence interval (CI): 1.23, 2.30) than women with an age at menarche of 13 years (Table 3 , crude model). This association was slightly attenuated after adjustment for mother's highest completed educational qualification (RR = 1.66, 95% CI: 1.21, 2.27) and when baseline nulliparity, diagnosis of polycystic ovary syndrome, and physical activity were taken into account (RR = 1.65, 95% CI: 1.20, 2.25). Additional adjustment for BMI in the final model attenuated the estimate further, but the association remained significant, showing a 51% higher risk of GDM for women with early menarche (95% CI: 1.10, 2.07). For each year of earlier menarche, risk of developing GDM was 10% higher (95% CI: 1.02, 1.18) after adjustment for all relevant GDM risk factors ( Table 3) .
The association between younger age at menarche and GDM was not significantly modified by birth weight, weight during childhood, mother's or participant's own highest educational qualification, diagnosis of polycystic ovary syndrome, parity, physical activity, or BMI (all P's for interaction > 0.20). BMI increased slightly over time, from a mean of 23.5 (SD, 4.5) at survey 2 to 25.4 (SD, 5.2) at survey 6; however, results were similar when adjusting for prepregnancy BMI at baseline or at the time of the survey prior to the index pregnancy (data not shown).
Compared with women who were included in the analysis (n = 4,749), women who were excluded because of missing covariate data (n = 919) were more likely to have a mother with an unknown highest educational qualification, to have a lower educational qualification themselves, to be parous (to have given birth at least once), and to have a sedentary/low level of physical activity (Web Table 1 ). No significant differences were found between included and excluded women regarding age at menarche, GDM incidence, and BMI. Conclusions on the association between age at menarche and GDM remained similar in an analysis where missing covariate data were imputed (Web Table 2 ). Women who were lost to follow-up were less likely to develop GDM (6.8% of women followed up for 3 years developed GDM (n = 4,631), as compared with 7.7% who were followed up for the full 12 years (n = 4,073)). However, the mean age at menarche and the proportion of women with early menarche did not differ according to follow-up time of 3, 6, 9, or 12 years (mean age at menarche = 12.9 years (SD, 1.4); menarche at age ≤11 years: 12.5% of women). Results derived using survival analysis were similar to those derived with log-binomial regression (data not shown), indicating that the unequal follow-up due to attrition did not influence our findings.
DISCUSSION
Findings from this population-based cohort study of Australian women indicated that earlier menarche is significantly associated with higher risk of developing GDM among women who report a live birth during 12 years of follow-up. Compared with women who had their first menstruation at age 13 years, women with menarche at or before age 11 years had a 51% higher risk of GDM after control for early-life, reproductive, and lifestyle factors and BMI.
We are aware of 2 previously published studies from the United States that have examined this association (9, 10). In the Omega Cohort Study, Dishi et al. (10) recruited women who visited prenatal care clinics prior to 16 weeks' gestation and followed them until delivery (n = 3,490). Age at menarche was not associated with GDM in these women (10) . Although a similar proportion of women had early menarche (14.5% at age ≤11 years) as in our population-based study (12.5%), women participating in the Omega Cohort Study had higher educational levels, were more likely to be parous at baseline, were less likely to be overweight or obese before pregnancy, and had a lower prevalence of GDM (5.3% vs. 7.5%), which may explain the inconsistency with our findings.
In line with our study, among 27,482 women in Nurses' Health Study II, age at menarche ≤11 years was associated with higher risk of developing GDM after adjustment for age, parity, family history of diabetes, smoking, oral contraceptive use, physical activity, birth weight, and childhood BMI (RR = 1.34, 95% CI: 1.14, 1.58) as compared with women with menarche at age ≥14 years (9) . In contrast to our findings, however, this association did not remain statistically significant after adjustment for adulthood BMI. Although the proportion of women who were overweight or obese in Nurses' Health Study II was comparable with that in our study (approximately 40% among women with early menarche), differences such as the larger proportion of parous women (60% as compared with 15% in our study), the older mean age at pregnancy (34 years (SD, 4.0) as compared with 29 years (SD, 4.5)), and the inclusion of recurrent cases (346 of 1,404 cases, compared with merely incident cases in our study), may have contributed to the inconsistency with our findings.
Several cohort studies from different countries have examined the association between age at menarche and risk of type 2 diabetes among nonpregnant populations. In a metaanalysis including 315,428 women from 3 cross-sectional studies and 7 prospective cohort studies that adjusted for BMI, risk of type 2 diabetes was 22% higher (95% CI: 1.17, 1.28) for the lowest category of age at menarche compared with the middle or highest category (3). Even though the overall summary estimate showed significantly increased risk of type 2 diabetes, individual study findings were inconsistent (3). Of the 10 studies included, 3 studies found no association (19-21) and 2 studies showed an association between younger age at menarche and higher risk of type 2 diabetes (22, 23); however, in 5 studies included in the meta-analysis, this association appeared to be completely mediated through adult BMI (24) (25) (26) (27) (28) . The 2 studies that found an association that was independent of adulthood BMI included both pre-and postmenopausal women, whereas studies that did not find an association included only postmenopausal women (3). Moreover, early menarche was associated with higher risk of type 2 diabetes after adjustment for adulthood BMI in younger women in Nurses' Health Study II, but not in older women in the Nurses' Health Study (26) . This may suggest that other pathways beyond BMI, such as hormonal changes, play a role in the association between menarche and younger onset of type 2 diabetes (3, 26) . This is in line with our finding that BMI did not completely attenuate the relationship between early menarche and GDM in our population of reproductive-aged women.
Several biological mechanisms may explain the association between earlier menarche and higher risk of GDM. A potential pathway may be excessive growth and adiposity in childhood leading to earlier menarche (29) , which in turn is associated with greater accumulation of adipose tissue that increases the risk of elevated blood glucose levels and insulin resistance (30, 31) , thereby increasing risk of developing GDM. The nature of the association between earlier menarche and greater adulthood adiposity remains unclear; however, this might reflect the higher childhood body fatness in girls with earlier menarche and the tracking trajectory of BMI from childhood to adulthood (32) . In our study, we found that birth weight and childhood weight were no longer significant covariates of the association between age at menarche and GDM when adulthood BMI was taken into account. The association was substantially attenuated after additional adjustment for adulthood BMI. Younger age at menarche is a risk factor for overweight and obesity, which in turn is a strong risk factor for GDM, indicating that BMI may lie on the causal pathway of this association.
Despite the large attenuation resulting from adjustment for BMI, a strong inverse association persisted, suggesting that in addition to BMI, additional pathways beyond adiposity play a role. Higher estrogen levels and lower sex hormone-binding globulin levels may be associated with earlier menarche and have been suggested to play a role in the pathogenesis of type 2 diabetes (33, 34) . An association between timing of menarche and GDM independent of BMI may therefore be biologically plausible through hormone exposure and changes in glucose metabolism. Genetic factors may be another possible cause of the higher GDM risk among women with early menarche. Timing of menarche has a high degree of heritability; it is estimated to be between 57% and 82% (35, 36) . In animal studies, it was found that overexpression of the mouse Lin-28 homolog A c Results were additionally adjusted for nulliparity (nulliparous (no previous births), parous status (having given birth at least once)), polycystic ovary syndrome (yes, no), and physical activity (sedentary/low, moderate, high).
d Results were additionally adjusted for baseline body mass index (underweight, healthy weight, overweight, obese).
(C. elegans) gene (Lin28a) results in both delayed puberty and insulin sensitivity and glucose intolerance (37, 38) , suggesting a possible direct link between early menarche and diabetes risk. Childhood diet (39) and exposure to stress during early life, such as family conflict, divorce, and abuse (4), are potentially modifiable common causes of young age at menarche and GDM (40) ; however, further studies are needed to examine whether and to what extent early menarche can be prevented during childhood. Strengths of this study include the prospective design and the large sample size. Furthermore, the ALSWH is a nationally representative population-based study, and results are generalizable to the Australian population of reproductiveaged women (11, 13) . We adjusted for a wide range of GDM risk factors, including childhood and adulthood risk factors. A number of limitations of the study should be acknowledged as well. First, age at menarche was selfreported and recalled at ages 22-27 years, which could have caused misclassification. Reporting of age at menarche could not have been influenced by the subsequent development of GDM, however, because of the prospective design of the study. Moreover, previous studies have shown that age at menarche is usually well recalled into adulthood (41, 42) . Second, the use of self-reported GDM may have introduced bias; however, reliability of self-reported GDM diagnosis in our study population showed high agreement with administrative records (16) . The universal GDM screening policy in Australia minimizes the risk of missing cases (15) . Third, even though extensive data have been collected on many population characteristics, we were not able to control for some potential confounding factors. Age at menarche and GDM may share several risk factors during early life. In our study, we adjusted for mother's highest educational qualification as a marker for early childhood exposures; however, no information was available on perinatal characteristics such as maternal nutrition and disease or on other early-life factors (40) . Unmeasured or imprecisely measured factors may have confounded the association.
In conclusion, younger age at menarche was associated with a significantly higher risk of GDM after control for known GDM risk factors. A history of early menarche may be clinically useful for identifying women at higher risk of developing GDM. Adjustment for adulthood BMI as a potential pathway resulted in substantial attenuation but did not fully explain the association, suggesting that avoidance of adulthood overweight and obesity by women with early menarche may lower their risk of GDM. Our findings suggest that age at menarche may be important in the etiology of GDM, but these results require replication in other study populations. Future studies starting before menarche, or even prenatally, are needed to elucidate the role of early-life exposures and weight trajectories in the association between age at menarche and subsequent risk of GDM.
